Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA

Megna Michael R sold 4,600 Kiniksa Pharmaceuticals International, Plc shares (Form 4)

Traded Jul 15 to Sep 3, 2026 · Filed Sep 3, 2026

From Jul 15 to Sep 3, 2026, Megna Michael R (CHIEF ACCOUNTING OFFICER) sold 4,600 Kiniksa Pharmaceuticals International, Plc shares at US$80.30 for US$369K under a trading plan, leaving 29,062 shares. Filed Sep 3, 2026 (Form 4).

Sold
4,600 shares
Price
US$80.30
Value
US$369K
Holding after
29,062 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF ACCOUNTING OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Class A Ordinary ShareAward279US$33.5027,697Direct
Sep 1, 2026Class A Ordinary ShareOption exercise3,93231,629Direct
Sep 1, 2026Class A Ordinary ShareOption exercise2,55834,187Direct
Sep 1, 2026Class A Ordinary ShareOption exercise2,36236,549Direct
Sep 1, 2026Class A Ordinary ShareOption exercise2,64439,193Direct
Sep 1, 2026Class A Ordinary ShareShares withheld for tax5,531US$79.2833,662Direct
Sep 3, 2026Class A Ordinary ShareSale4,600US$80.3029,062Direct

Source

View original at SEC

Related